Get started
Author

Carmen Alcalá

Encephalitis with refractory seizures, status epilepticus, and antibodies to the GABAA receptor: a case series, characterisation of the antigen, and analysis of the effects of antibodies
2014 · Mar Petit-Pedrol, Thaís Armangue, et al. · The Lancet Neurology · 629
Analysis of theC9orf72Gene in Patients with Amyotrophic Lateral Sclerosis in Spain and Different Populations Worldwide
2012 · Alberto García-Redondo, Oriol Dols-Icardo, et al. · Human Mutation · 98
Combined Cerebrospinal Fluid Neurofilament Light Chain Protein and Chitinase-3 Like-1 Levels in Defining Disease Course and Prognosis in Multiple Sclerosis
2019 · Sara Gil-Perotin, Jessica Castillo-Villalba, et al. · Frontiers in Neurology · 79
PDF
Autologous hematopoietic stem cell transplantation in relapsing-remitting multiple sclerosis: comparison with secondary progressive multiple sclerosis
2017 · Bonaventura Casanova, Isidro Jarque, et al. · Neurological Sciences · 62
PDF
Efficacy and safety of rituximab in relapsing and progressive multiple sclerosis: a hospital-based study
2018 · Carmen Alcalá, F. Gascón, et al. · Journal of Neurology · 56
Onset of secondary progressive multiple sclerosis is not influenced by current relapsing multiple sclerosis therapies
2018 · Francisco Coret, Francisco C Pérez-Miralles, et al. · Multiple Sclerosis Journal - Experimental Translational and Clinical · 40
CSF chitinase 3-like-1 association with disability of primary progressive MS
2020 · Francisco Pérez-Miralles, Daniel Prefasi, et al. · Neurology Neuroimmunology & Neuroinflammation · 39
PDF
Cross-reactivity of a pathogenic autoantibody to a tumor antigen in GABA A receptor encephalitis
2021 · Simone M. Brändle, Manuela Cerina, et al. · Proceedings of the National Academy of Sciences · 34
Treatment with alemtuzumab or rituximab after fingolimod withdrawal in relapsing–remitting multiple sclerosis is effective and safe
2019 · Carmen Alcalá, F. Gascón, et al. · Journal of Neurology · 31
High Levels of Cerebrospinal Fluid Kappa Free Light Chains Relate to IgM Intrathecal Synthesis and Might Have Prognostic Implications in Relapsing Multiple Sclerosis
2022 · Jéssica Castillo-Villalba, Sara Gil-Perotín, et al. · Frontiers in Immunology · 26
Effectiveness of rituximab vs. ocrelizumab for the treatment of primary progressive multiple sclerosis: a real-world observational study
2022 · Carmen Alcalá, Carlos Quintanilla-Bordás, et al. · Journal of Neurology · 25
Recurrent and universal alopecia areata following alemtuzumab treatment in multiple sclerosis: A secondary autoimmune disease
2018 · Carmen Alcalá, F. Pzére-Miralles, et al. · Multiple Sclerosis and Related Disorders · 22
An expanded parenchymal CD8+ T cell clone in GABAA receptor encephalitis
2020 · Aline Bracher, Carmen Alcalá, et al. · Annals of Clinical and Translational Neurology · 21
PDF
Assessment of neuronal and glial serum biomarkers in myelin oligodendrocyte glycoprotein antibody-associated disease: the MULTIMOGAD study
2025 · Romain Marignier, Javier Villacieros-Álvarez, et al. · Journal of Neurology Neurosurgery & Psychiatry · 17
Case Report: Exacerbation of Relapses Following mRNA COVID-19 Vaccination in Multiple Sclerosis: A Case Series
2022 · Carlos Quintanilla-Bordás, Francisco Gascón-Gimenez, et al. · Frontiers in Neurology · 16
PDF
Eculizumab for a catastrophic relapse in NMOSD: case report
2023 · David Gorriz, Francisco Carlos Pérez-Miralles, et al. · Neurological Sciences · 15
Design and Validation of an Expanded Disability Status Scale Model in Multiple Sclerosis
2021 · Antonio Barreiro-González, Maria T. Sanz, et al. · European Neurology · 11
Magnetic resonance imaging and optical coherence tomography correlations in multiple sclerosis beyond anatomical landmarks
2020 · Antonio Barreiro-González, Maria T. Sanz, et al. · Journal of the Neurological Sciences · 11
Long-term outcome in patients with carotid artery stenting and contralateral carotid occlusion: a single neurovascular center prospective analysis
2011 · Aida Lago, Vera Parkhutik, et al. · Neuroradiology · 11
Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated Disease
2025 · Javier Villacieros-Álvarez, Carmen Espejo, et al. · Neurology Neuroimmunology & Neuroinflammation · 10
Rheological alterations and thrombotic events in patients with systemic lupus erythematosus
2012 · Amparo Vayá, Javier Calvo, et al. · Clinical Hemorheology and Microcirculation · 9
Profile and Usefulness of Serum Cytokines to Predict Prognosis in Myelin Oligodendrocyte Glycoprotein Antibody−Associated Disease
2025 · Javier Villacieros-Álvarez, Carmen Espejo, et al. · Neurology Neuroimmunology & Neuroinflammation · 8
Treatment of multiple sclerosis with rituximab: A Spanish multicenter experience
2023 · Francisco Gascón-Giménez, Carmen Alcalá, et al. · Frontiers in Neurology · 8
Different clinical response to interferon beta and glatiramer acetate related to the presence of oligoclonal IgM bands in CSF in multiple sclerosis patients
2018 · Bonaventura Casanova, Laura Lacruz, et al. · Neurological Sciences · 8
Oligoclonal M bands unveil occult inflammation in multiple sclerosis
2022 · Bonaventura Casanova, Jessica Castillo, et al. · Multiple Sclerosis and Related Disorders · 6
Works count: 39
Citation count: 1,305
H-index: 15
I10-index: 20
Year
Topic
Type